Normatense, 20 pcs.

Special Instructions

Since the effect of Normatens develops relatively slowly, the dosage should not be increased more often than once a week, due to the possibility of a pronounced decrease in BP; special care should be taken in case of combined use with other antihypertensive agents; during treatment, periodically monitor BP levels to determine the optimal dosing regimen.

Contraindications

• High sensitivity to any of the ingredients.
• Depression
• Epilepsy.
• Parkinson’s disease
• Companied by electroconvulsive therapy.
• Pheochromocytoma.
• Co-treatment with monoamine oxidase (MAO) inhibitors.
• Gastric and duodenal ulcer in the acute phase.
• Erosive gastritis.
• Nonspecific ulcerative colitis.
• Stenocardia.
• Last seen myocardial infarction.
• Chronic heart failure.
• Veep bradycardia.
• Atrioventricular block.
• Intraventricular block.
• Severe renal failure (CK below 30 ml/min).
• Nephritis.
• Uremia.
• Nephrosclerosis.
• Arterial hypotension.
• Severe cerebral atherosclerosis.
• Severe hepatic dysfunction.
• Addison’s disease.
• Hypokalemia.
• Hyponatremia.
• Hypochloremia.
• Hyperuricemia with clinical manifestations.
• Open angle glaucoma.
• Hematopoiesis disorders.
• Pregnancy.
• Period of lactation.
• Bronchial asthma.
• Age under 18 years of age (efficacy and safety of use not established).

With caution:

• Diabetes mellitus.
• Gout.
• Elderly age.

.

Side effects

Digestive system: diarrhea, dry mouth, abdominal pain, nausea, vomiting, aggravation of peptic ulcer disease, decreased appetite. Rarely – ulceration of the mucous membrane of the stomach and duodenum, gastrointestinal bleeding when using Reservin at a dose above 1 mg/day (the amount contained in 10 tablets of Normatense).

Overdose

Symptoms: nausea, vomiting, diarrhea, muscle weakness, dizziness, headache, marked BP decrease, bradycardia, arrhythmias, depression, hyporeflexia, confusion and coma.

Pregnancy use

Since reserpine has teratogenic effect, it is not recommended to use Normatense during pregnancy.